Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...
Researchers at the University of Bonn have uncovered how a kidney RNA molecule can trigger autoimmune disease. In mice, a ...
ProQR ( ($PRQR) ) has issued an announcement. On November 3, 2025, ProQR Therapeutics hosted a virtual analyst and investor event to discuss its ...
The Brighterside of News on MSN
New molecule targets and destroys harmful RNA linked to cancer and aging
Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.
How do stem cells know what to become?Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still ...
Novel approach designed to address dysregulated RNA splicing events that drive tumor growth and disease progression across ...
News-Medical.Net on MSN
Mapping how the heart heals after a heart attack
Over the course of evolution, the human heart has largely lost its ability to regenerate. Our distant ancestors were not ...
The Brighterside of News on MSN
Adults grow new brain cells well into their 70's, study finds
Challenging a long-standing assumption regarding the adult brain, recent research has demonstrated that individuals can ...
9hon MSN
Evolutionary comparison points to pigs as superior models for human pancreas and diabetes research
Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...
Investor webcast to be held on Monday November 3, 2025 at 8:00 am ESTHAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene ...
For $55 million, Roche gains access to Manifold Bio’s drug discovery technology, which will be used to develop new “shuttles” that can get medicines across the blood-brain barrier.
BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results